Latest / Stock Movers / Home Depot Climbs, Pfizer Rises, Amer Sports Rallies on Earnings
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News. The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg data.
- 0:16Speaker 2: Let's look at some of the movers though.
- 0:18Speaker 1: Today.
- 0:18Speaker 2: I'm Alex Stee alongside Paul Sweeney. We're joined now by
- 0:20Speaker 2: Bloomberg's Lisa Matteo. Lisa, you're looking at Home Depot. Yeah, okay,
- 0:24Speaker 2: So Home Depot right opened its book shares have been
- 0:26Speaker 2: kind of all over the map though, up as much
- 0:28Speaker 2: as two percent, but now it's starting to take lower. Basically,
- 0:32Speaker 2: it's the CFO said February sales weight on the quarter
- 0:35Speaker 2: due to Nation one weather conditions because of the weather,
- 0:37Speaker 2: but demand improved in March and April, so it maintained
- 0:41Speaker 2: its guidance for the fiscal year. US sales ticked up
- 0:44Speaker 2: and that's full year Foe gust. It did include the
- 0:46Speaker 2: impact of tariffs, says sources more than it sources more
- 0:50Speaker 2: than fifty percent of its products in the US. Is
- 0:53Speaker 2: it a sign that consumer spending is holding up? I mean,
- 0:56Speaker 2: that's a question. I went to Home Depot, you know,
- 0:58Speaker 2: over the weekend, and it was it was I had
- 1:00Speaker 2: to get the plans and the soil and all that
- 1:02Speaker 2: kind of stuff you know, in the spring, and it
- 1:05Speaker 2: was crowded. But they say that sales got a knight's
- 1:07Speaker 2: boost from yes, the smaller projects things like that, but
- 1:11Speaker 2: consumers are still holding off on those bigger projects.
- 1:13Speaker 1: What's going on with Pfizer?
- 1:15Speaker 2: Okay, so there was this big news from Pfizer right struck,
- 1:17Speaker 2: this six billion dollar licensing deal with Chinese biotech company
- 1:20Speaker 2: three S Bio. Basically they're going to develop a cancer
- 1:24Speaker 2: drug outside of China. So Pizer has been up as
- 1:27Speaker 2: much as about three percent, but shares of three S
- 1:30Speaker 2: Bio of thirty two percent in Hong Kong, so a
- 1:32Speaker 2: big deal there. The breakdown as far as that's six billion,
- 1:35Speaker 2: so you have Fizer paying about one point two five
- 1:38Speaker 2: billion upfront to license data experimental drug, and then in
- 1:41Speaker 2: addition to that, three S Bio can get up to
- 1:44Speaker 2: four point eight billion in downstream fees if the drug
- 1:47Speaker 2: hits all milestone. So that's how that whole six billion
- 1:50Speaker 2: works out. But it's not just fiber Pfizer. It's like
- 1:53Speaker 2: a lot of competition has been set on China originated
- 1:55Speaker 2: drugs to kind of refill their pipelines over the past year.
- 1:58Speaker 2: I mean, you have global data saying the number of
- 2:00Speaker 2: large farm of licensing deals from China reached a record
- 2:02Speaker 2: high in twenty twenty four, So more companies are starting
- 2:04Speaker 2: to do this. What else you got and so Omer Sports,
- 2:08Speaker 2: Okay they make the Wilson tennis rackets, Louisville Slugger bats.
- 2:11Speaker 2: I know my money goes to that De Marini bats.
- 2:14Speaker 2: On top of it, it shares have been up as
- 2:16Speaker 2: much as seventeen percent, so it boosted its adjusted profit
- 2:19Speaker 2: forecast for the full year. Right reported first quarter results
- 2:22Speaker 2: topped expectations. A big part of it Solomon ski boots.
- 2:26Speaker 2: I hear the skimer, Okay, you're the skier. I know,
- 2:29Speaker 2: I'm not the big time skier. Arctics, the hiking gear.
- 2:33Speaker 2: I don't know if anyone's into that too. Those are
- 2:34Speaker 2: like the big movers for them when it comes to tariff.
- 2:38Speaker 2: So the company just says it, you know what, We're
- 2:39Speaker 2: going to manage through it because we have these premium brands.
- 2:42Speaker 2: They said they're going to continue to operate its business
- 2:44Speaker 2: with flexibility in their fourth quarter report, though they did
- 2:48Speaker 2: talk a lot about twenty percent of their sourcing came
- 2:51Speaker 2: from China, Vietnam, Canada, and Mexico in twenty twenty four.
- 2:55Speaker 2: China and Vietnam made up the most of that, but
- 2:57Speaker 2: they're saying they're going to weather through the storm, the
- 2:59Speaker 2: tariff storm.
- 3:01Speaker 1: The Stockmover's report from Bloomberg Radio. Check back with us
- 3:05Speaker 1: throughout the day for the latest roundup of companies making
- 3:08Speaker 1: news on Wall Street and for the latest market moving headlines.
- 3:12Speaker 1: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 3:16Speaker 1: dot com, and on Applecarplay and Android Auto with the
- 3:19Speaker 1: Bloomberg Business app.